Problem: GDM has been associated with disturbances in iron homeostasis and exaggerated immune activation. We sought to investigate the extent to which placental iron storage and macrophage accumulations were altered in GDM.
| INTRODUC TI ON
Gestational diabetes mellitus (GDM) is the most common metabolic disorder during pregnancy with a mean prevalence in North America and the Caribbean of 7%. 1 It is defined as glucose intolerance newly diagnosed in the second or third trimester of pregnancy. 2 GDM significantly increases the risk of pregnancy complications, including fetal macrosomia, neonatal hypoglycemia and hypocalcemia, preeclampsia, premature labor, and Cesarean delivery. 2 It also increases the risk of postpartum complications in mother and child including late-onset diabetes and cardiovascular disease. 2 The risk of GDM is increased significantly by concomitant obesity, which is itself an increasing problem globally, and is directly associated with pre-pregnancy BMI. 3 In the United States alone, approximately 55% of women of childbearing age are either overweight or obese. 4 Compared to women with normal pre-pregnancy BMI, the odds of developing GDM increase 1.97 for overweight women, 3.01 for those classified as obese, and 5.55 for morbidly obese women. 5 A major barrier to reducing the complications of GDM is a lack of clarity regarding the underlying pathophysiological mechanisms contributing to the impact of the disease, particularly on offspring.
The placenta is a transient, but complex organ, acting as the link between the mother and the developing fetus. It is increasingly appreciated to be a target organ of GDM. It plays important roles throughout pregnancy, mediating the selective exchange of nutrients, waste, gases, and other modulatory factors across the maternal/fetal interface. 6 The placenta also orchestrates and maintains maternal/fetal immune tolerance and acts in an endocrine fashion by producing key modulatory hormones while separating the fetus from a possibly adverse or harmful maternal environment. 6 Maternal hyperglycemia, as observed in GDM, alters placental morphometric characteristics, changes the structural integrity of syncytiotrophoblasts, and provokes major changes in placental gene expression related to chronic stress and inflammation.
7-9
Elevated biomarkers of systemic maternal inflammation have been described in women with GDM, including an increase in circulating levels of interleukin (IL)-6, IL-8, IL-18, and C-reactive protein (CRP) in conjunction with decreased levels of IL-10. 10 T-cell directed immunoregulation is skewed in patients with GDM, as evidenced by reduced development and suppressive capacity of regulatory CD4 + T-cell (T reg )
populations. 11, 12 Multiple studies have shown that in conjunction with an increase in maternal circulating inflammatory mediators, GDM is also associated with pro-inflammatory changes within the placenta. 8, 10, 13, 14 In particular, macrophages, the primary phagocyte in the healthy placenta, appear to be impacted by this endocrine disorder.
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Macrophages function as a first line of antimicrobial defense, modulate tissue homeostasis, and are abundant in the placenta throughout pregnancy. 15 Placental macrophages consist of both fetally derived macrophages, known as Hofbauer cells (HBC), which are found in the villous core, and maternally derived decidual macrophages, which reside in the maternal decidua. 16 HBCs have been characterized as having an anti-inflammatory (M2) profile, characterized by high cell surface expression of the receptors CD163, CD209, and CD206, and increased secretion of IL-10 and transforming growth factor (TGF)-β. [18] [19] [20] Furthermore, the DNA methylation pattern of HBCs is consistent with an anti-inflammatory phenotype. 21 The documented anti-inflammatory phenotype and importance of placental macrophages in maintaining immune tolerance suggest that these cells play a regulatory role within the placenta. Diabetes during pregnancy has been shown to induce a pro-inflammatory phenotype in placental macrophages, as characterized by an increase in the expression of IL-1β and CCR7 and a decrease in the anti-inflammatory markers CD163, CD209, and IL-10. 16 A recent study, however, concluded that HBCs maintain their anti-inflammatory phenotype even in the presence of GDM. 22 Thus, there is some controversy regarding the impact of GDM on placental macrophages and the inflammatory state of the placenta.
An identifying characteristic of placental macrophages is a high level of the anti-inflammatory marker CD163, which is involved in the clearance of hemoglobin-haptoglobin complexes and iron uptake.
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The role of CD163 in iron recycling and handling is especially of interest in GDM as iron-containing proteins, iron availability, and levels of CD163 differ between women with GDM and non-diabetic pregnancies. [24] [25] [26] [27] [28] [29] Circulating levels of hemoglobin and iron are higher in GDM patients compared to controls. 24 Elevated iron stores, as estimated by increased maternal serum hepcidin and ferritin levels, may be involved with the development of GDM. 25, 27, 29 Two independent studies have shown that antenatal iron supplementation, leading to increased levels of maternal iron, increased the risk of GDM and was associated with glucose impairment and hypertension throughout gestation suggesting a link between imbalanced iron homeostasis and GDM. 26, 28 Given the relationships among GDM, placental macrophage activation, and iron homeostasis, we sought to conduct a retrospective, casecontrol study of archived human placental tissue from women with or without GDM to better define placental pathology, placental iron stores, and both macrophage density and CD163 expression in situ. 
| Participants
Our initial query identified 1292 possible GDM cases and 554 possible control cases ( Figure 1 ). The number of participants in this study was limited to 25 patients with GDM and 25 matched controls. The study design and sample distribution are outlined in Figure 1 . In some instances, full-thickness cross sections containing the decidua, placental disk, and chorion were unavailable. For these patients, pairs of blocks jointly forming a full-thickness cross section
were obtained for analysis. Serial sections were prepared from the FFPE blocks and were stained with hematoxylin and eosin (H&E),
Prussian blue, CD163, and CD68 at TPSR using standard protocols.
Some requested samples were unavailable or in poor quality and, thus, were excluded from the study. While other samples, once cut from the FFPE blocks and stained, were missing sections of the decidua, chorion, or both. When this occurred, we excluded the corresponding tissue section in the matched sample. In total, 22 FFPE blocks from cases and 22 FFPE blocks from controls were available for analysis ( Figure 1 ).
All H&E-stained slides were reviewed by a pathologist (JAG) blinded to GDM status and prior diagnostic findings using a custom data entry form. Amnion, villous disk, and decidual surface were systematically evaluated for multiple abnormalities including meconium-laden macrophages, acute inflammation, infarcts, hydrops, villous maturity, and decidual and fetal vessel maturation. This allowed for uniformity and comparability in description. Histological findings were determined using standard clinical criteria. Representative images were captured under bright-field illumination with automated exposure.
| Slide imaging and digital quantification
Slides were digitally scanned at 20 × magnification using a Leica SCN400 absent from a patient sample, the corresponding region was excluded from analysis for its matched control or case.
| Statistical analysis
Pearson's chi-squared and two-sample t tests were used to assess variation in categorical and continuous study participant characteristics, respectively. We used beta regression to predict the mar- 
| RE SULTS

| Study participant characteristics
Study participant characteristics and data gathered from the SD are summarized in Table 1 . The average maternal age for controls was 27.0 while cases had an average maternal age of 29.3 (SD for controls and cases was 5.5 and 5.8, respectively). Average gestational age at time of delivery for controls was 37.5 weeks and 37.2 for cases (SD for controls and cases was 2.1 and 1.8, respectively). The retrospective nature of this study limited our ability to collect BMI information on all subjects. The pre-pregnancy BMI and first trimester BMI information collected did not reveal significant difference between controls and cases. Placental weight and placental volume did not differ between cases and matched controls. The 50 g OGTT was elevated
in cases compared to controls, as expected. All control subjects had a normal 50 g OGTT; therefore, 3-hour OGTT was neither clinically indicated nor performed. Maternal hematocrit levels at delivery were significantly elevated in GDM women compared to controls at 35.3% vs 33% for controls (P = 0.02). In light of hematocrit differences between cases and controls, and given the relationship between iron and hemoglobin, we adjusted analyses for differences in maternal hematocrit levels.
| GDM placentae exhibit an increase in abnormal histology
Meconium-laden macrophage levels within the amnion of GDM placentae were significantly higher at 36.4% compared to 4.6% of controls. Correspondingly, a greater percentage of GDM placentae showed amnion epithelial reactive changes suggestive of meconium exposure -68.2% of GDM placentae versus 36.4% of controls (Table 2 , Figure 2 ). These differences remained statistically significant after adjustment for maternal hematocrit.
GDM placentae exhibited abnormal villous size compared to controls with the GDM placentae showing signs of accelerated maturation for gestational age. When adjusted for maternal hematocrit levels, however, the difference was no longer significant. The presence of calcifications was significantly increased in GDM placentae in the crude, but not adjusted analysis (Table 2 ).
| CD163 and iron storage are increased in GDM placentae
To examine the impact of GDM on placental macrophages and iron stores, we stained full placental cross sections for CD68, CD163, and iron. The chorion of GDM placentae contained a significantly higher number of moderately stained CD163-positive cells com- The higher expression of CD163 in the placentae of GDM mothers remained significant after adjustment for maternal hematocrit (Table 3) .
We examined the amount of iron storage within the placenta by Prussian blue staining. The difference in Prussian blue stained positive area was not significantly different in the chorion or decidual areas independently of the villous core (Table 3) . However, we observed a significant increase in iron-positive area within the entire tissue, indicating that the increase in iron staining was localized to the fetally derived villous core. The difference remained significant after adjustment for the maternal hematocrit levels.
| D ISCUSS I ON
A growing body of evidence suggests and supports an association between GDM and altered histological and physiological characteristics within the placenta, an increase in maternal and placental inflammation, and an increase in maternal iron status [7] [8] [9] [10] [11] [12] [15] [16] [17] 24, 25, 27, 29, 32 In this study, we used a novel approach to retrieve archived placental tissue linked to deidentified patient records to investigate differences in placental histology, placental macrophage number, distribution, CD163 expression, and iron storage within the placenta to gain a better understanding of how GDM affects these placental characteristics. Indeed, we found an increase in abnormal placental histological characteristics, and increase in CD163 expression, and an increase in iron storage within the placenta of women with GDM.
The findings presented here shed light on specific pathological and cellular changes that occur within the placenta as a result of GDM. b Odds ratios for histological features for more than two levels were calculated using polytomous regression. All other odds ratios are from logistic regression models.
These changes may mediate the pre-and postnatal complications associated with GDM and confirm the need to look further into the role of iron and iron supplementation during pregnancy in women at risk for GDM.
| GDM and maternal hematocrit
Our study identified an association between GDM and an increase in maternal hematocrit level, which is consistent with reports in pregnant and non-pregnant persons with diabetes. Associations between hematocrit levels and diseases of insulin resistance and metabolic syndrome have been reported; however, associations vary depending on study design and population. [33] [34] [35] [36] [37] Lao reported women with GDM have higher hemoglobin, red blood cell count, and hematocrit levels in the third trimester, but not earlier in gestation. 38 Another study reported no increase in hematocrit levels during pregnancy in cases of GDM; however, they described an increase in maternal hemoglobin levels throughout the duration of pregnancy and have a high hemoglobin and hematocrit level at baseline. 39 Elevated hematocrit levels have been reported to be an independent risk factor for the development of type 2 diabetes and impaired glucose tolerance. 34 Hyperinsulinemia and insulin resistance are features of metabolic syndrome, type 2 diabetes, and GDM. Hematocrit levels increase as a result of increased erythropoiesis, which might explain the increase observed in GDM patients. Previous studies have provided evidence for a relationship between hyperinsulinemia and an increase in erythropoiesis. 33 Insulin resistance is associated with increased levels of insulin-like growth factor-1, which may lead to an increase in erythropoiesis, hence, increasing hematocrit levels within GDM patients. This phenomenon has been demonstrated previously in rats. 40 In healthy individuals, an increase in hematocrit levels would suggest superior oxygen delivery throughout the body. Alternatively, it is possible that GDM causes worse oxygen delivery to the placenta and the combination of elevated hematocrit levels and accelerated villous maturation that we report here are compensatory responses to an increased need for oxygen within the 
| Placental histopathological changes in GDM
The histopathological changes identified in the placentae of women with GDM were heterogeneous and varied in their severity. Our analysis discovered a significant increase in the presence of meconium- 
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Villi arborize and mature throughout gestation, with more mature villi showing a smaller cross section and peripheral capillaries. 43 These changes can be expected to maximize surface area and thus oxygen diffusion. Villous maturation varies in pathologic Iron circumstances-immature villi have been repeatedly reported in GDM, while precocious maturity has been reported in conditions with impaired maternal-fetal circulation. 32, 43, 44 In clinical practice, as in this study, villous maturation is based on a gestalt impression, rather than systematic measurement. Perhaps surprisingly, this gestalt impression has been shown to correlate with maturation-based gene expression changes. 45 It is unclear why our results differ from previously reported studies in GDM. There are several minor methodologic differences; however, the most likely cause is the use of a retrospective case: control design with matching by maternal and gestational age in the present study as compared to the prospective cohort-based designs in other studies. As noted in the results, the difference in villous maturation was no longer apparent when controlling for hematocrit.
This suggests a unifying mechanism wherein GDM impairs oxygen delivery to the placenta, thus, inducing the compensatory responses of accelerated villous maturation and increased red cell mass.
The presence of villous calcifications was elevated in GDM placentae compared to controls prior to adjustment for maternal hematocrit levels, with a fairly large effect size (unadjusted odds ratio of 4.67 (95% confidence intervals of 1.30-16.76, Table 2 ).
Calcifications are indicative of an aging placenta. 46 The clinical significance of such calcifications is not well defined although calcification is likely due to an increase in available calcium and phosphate within the placenta. 46 Prominent in late-term and post-term placentae, they can occur in the absence of other placental pathologies, particularly in peripheral areas. However, the mineralization process through which calcifications occur may be accelerated in some disorders of pregnancy. The early appearance of calcifications may represent accelerated placental maturation and or senescence brought about as a result of fetal stress and maternal complications such as maternal hypertensive disorders. 47 Quinlin and colleagues first noted that placentae from pregnancies complicated by diabetes develop calcifications earlier in gestation than non-complicated pregnancies and may represent early placental dysfunction. 47 Although significance was lost after adjustment for maternal hematocrit, the effect size was 3.70 (95% confidence intervals of 0.86-16.89), suggesting that the small samples size might have played a role in the lack of significance.
A difference in placental calcifications indicates that GDM may influence nutrient availability within the placenta as well as leading to accelerated placental maturation and cellular senescence. The hypothesis that GDM may accelerate placental maturation is further strengthened by our reported finding that we observed an increase in villous maturation within the GDM cohort compared to control.
The mechanism driving the accelerated maturation which could be linked to an increase in villous calcifications is yet to be defined.
| Placental macrophages and GDM
CD68 is a pan-macrophage marker found on monocytes and macrophages. 48 We utilized this marker as way to localize and enumerate macrophages within the placenta. Our study identified no significant difference in the number or distribution of placental CD68 + cells between cases and controls. Another study which looked for CD68 expression levels within placental tissue of GDM and control patients found no significant difference in the levels of CD68 transcript levels. 49 These findings contradict other reports where increases in the mRNA expression of CD68, in conjunction with increased expression levels of IL-6 and TNF-α, were observed in pregnancies complicated with GDM. 14 
Mrizak et al also reported
an increase in transcript levels of CD68 and CD14, both common human monocyte/macrophage markers, within placenta recovered from women with GDM. 12 That study, however, only collected placentae from women diagnosed with GDM whose child was born A hemoglobin scavenger receptor that mediates the endocytosis of hemoglobin-haptoglobin complexes, CD163, is exclusively expressed on macrophages and is often utilized as a marker for placental macrophages. 20, 23 We identified an increase in CD163 + cells within the decidua of GDM placentae and an increase in the amount of moderately stained CD163 + cells within the chorion. Expression of CD163 has been associated with an anti-inflammatory (M2) macrophage phenotype. 49, 50 The putative relationship of CD163 to iron homeostasis and macrophage polarization is summarized in Figure 4 .
Anti-inflammatory mediators such as IL-10 promote the expression of CD163 while pro-inflammatory mediators such as IFN-γ and TNF-α have been shown to decrease its expression. 51 CD163 also exists in soluble form, sCD163. 52 Similar to TNF-α, the ectodomain of CD163
is cleaved from the surface of macrophages in an inflammation-driven fashion. 53 Levels of circulating sCD163 increase in mothers with GDM in conjunction with increases in circulating TNF-α and IL-6. 54 Placental tissue, as well as adipose tissue, from GDM mothers is a source of increased sCD163 circulating in maternal serum as described by placental and adipose tissue explant studies. 54 GDM appears to not only increase the expression of CD163 but also increase levels of sCD163 in maternal serum. These findings are in agreement with previous findings of elevated sCD163 in GDM. 54 The molecular mechanisms leading to the cleavage of CD163 from placental macrophages have yet to be elucidated in the case of GDM, so future attention should be paid to discovering the mechanisms involved in this phenomenon.
| Placental iron load increases in GDM
Placental iron load for the tissue as a whole was significantly increased in GDM. However, close examination of both the decidua and chorion independently revealed no difference, indicating that the increase in iron load within the placenta is found primarily within the fetally derived villous tissue. The opposite was found to be true for the presence of CD163. CD163 showed significance within the chorion and decidua individually, but not the tissue as a whole. The villous core, the majority of the placental specimen, is primarily fetally derived tissue, bathed in maternal blood, and acts as the site of exchange between maternal and fetal circulation. As this area is saturated in maternal blood, it makes sense that the villous core stores iron at a higher level than within the chorion or decidua. Iron enters and exits macrophages in many different forms through many different pathways, including CD163.
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If macrophage polarization is impacted in cases of GDM, the relative expression of CD163 as well as iron storages within the macrophage may be altered in response. As reviewed by Cairo et al, 57 macrophage iron metabolism is influenced by the local inflammatory environment.
If GDM influences the inflammatory environment, CD163 expression and iron storage within the placenta may be effected as well. Multiple other cell types within the placenta are involved in iron homeostasis.
Our findings of increased iron stores within GDM placentae correspond with previously reported data indicating that women with GDM have a significantly increased iron stores, as measured by hemoglobin, ferritin, and transferrin saturation. 24 The physiological mechanism driving the increase in stored iron and more information regarding the cells in which the iron is stored needs further investigation and may shed light onto the apparent link between GDM, iron, and possible mechanisms driving adverse phenotypes.
| Study limitations
Our study has important limitations, which may reflect the retrospective nature of, and small number of subjects included in this study. Our pilot study was relatively small and designed to be inclusive of a large range of maternal ages and gestational ages while representing diverse ethnicities. This inclusivity may have introduced variability into our results. Future studies should be designed to account for variability due to gestational age, maternal age, and ethnicity. The previously archived placental tissues included in this study were sent to pathology at the discretion of the obstetrician present at delivery. While there are recommended indications for placental examination, they are inconsistently followed. This could introduce difficult to measure confounders, as normal-appearing placentas from normal pregnancies are rarely sent for pathology. This study was likely underpowered to confirm a previously reported association between increased placental weight and GDM 58 . Although both placental weight and volume were higher in cases than in controls in our study, neither difference reached statistical significance. This may also reflect more aggressive treatment of GDM than in the time period when prior studies were conducted. 59 Our study lacked data on iron status in the mothers, a result of the retrospective nature of the study. This precluded incorporation of such knowledge into our analyses, potentially obscuring important relationships between maternal iron loads and placental pathology.
Future studies should examine comprehensively maternal iron status, including total iron, soluble transferrin receptor, erythropoietin levels, ferritin, and hepcidin values. Pre-pregnancy obesity is a risk factor for GDM, but we did not have pre-pregnancy height and weight measurements on most of the subjects in this study. Because gestational weight gain is an important factor in inflammatory processes and the development of GDM, this will need to be better analyzed in future studies.
Although we matched our GDM samples to our controls for variables such as maternal age and gestational age at birth, differences in other patient characteristics might have introduced variability.
Differences in some of our measured parameters may be evident in some subgroups for which this pilot study is undersized. The nature of FFPE placental tissue and the age of some of the blocks themselves did not allow us to gather quantifiable information on all sections of the placenta due to quality and loss of tissue.
| Conclusion
In conclusion, this study demonstrates that the presence of GDM influences multiple iron-related parameters including an increase in maternal hematocrit levels, an increase in CD163 within the chorion and decidua, and an increase in iron stores within the fetally derived villous core. Our results also highlight GDM's influence on multiple placental physiological parameters such as meconium-laden macrophages, placental villous size and maturation, and an increase 
